Concepedia

Author

Sikander Ailawadhi

Mayo Clinic in FloridaORCID

Also Known As

Ailawadhi Sikander, Ailawadhi, S., Jacobs, Benjamin, Lund, Jennifer L., S Ailawadhi, S. Ailawadhi, SIKANDER AILAWADHI, Sikander Ailawadhi, Singhal, Seema

703

Publications

7K

Citations

42

H-Index

101

Concepts

All Affiliations

Mayo Clinic in FloridaWinnMedMayo Clinic in ArizonaJacksonville CollegeMayo Clinic
SA

About

Sikander Ailawadhi is an author at Mayo Clinic in Florida specializing in medicine, oncology, and hematology.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

22

43

1.7K

2

Health Sciences

14

17

635

3

Public Health

9

9

330

4

Business

1

1

18

5

Education

1

1

17

Sikander Ailawadhi

×

126

Publications

5.1K

Citations

39

H-Index

YearCitations

Ide-cel or Standard Regimens in Relapsed and Refractory Multiple Myeloma

Paula Rodríguez‐Otero, Sikander Ailawadhi, Bertrand Arnulf,

New England Journal of Medicine

2023

627

IAP antagonists induce anti-tumor immunity in multiple myeloma

Marta Chesi, Noweeda Mirza, Victoria M. Garbitt,

Nature Medicine

2016

169

Treatment-Free Remission After Second-Line Nilotinib Treatment in Patients With Chronic Myeloid Leukemia in Chronic Phase

François-Xavier Mahon, Carla Boquimpani, Dong‐Wook Kim,

Annals of Internal Medicine

2018

127

Racial disparities in treatment patterns and outcomes among patients with multiple myeloma: a SEER-Medicare analysis

Sikander Ailawadhi, Kejal Parikh, Safiya Abouzaid,

Blood Advances

2019

124

Bortezomib, lenalidomide, and dexamethasone with or without elotuzumab in patients with untreated, high-risk multiple myeloma (SWOG-1211): primary analysis of a randomised, phase 2 trial

Saad Z. Usmani, Antje Hoering, Sikander Ailawadhi,

The Lancet Haematology

2020

122

A Phase 1 First in Human (FIH) Study of AMG 701, an Anti-B-Cell Maturation Antigen (BCMA) Half-Life Extended (HLE) BiTE® (bispecific T-cell engager) Molecule, in Relapsed/Refractory (RR) Multiple Myeloma (MM)

Simon J. Harrison, Monique C. Minnema, Hans C. Lee,

Blood

2020

112

Outcome disparities in multiple myeloma: a <scp>SEER</scp>‐based comparative analysis of ethnic subgroups

Sikander Ailawadhi, Ibrahim Aldoss, Dongyun Yang,

British Journal of Haematology

2012

110

Palliation of malignant dysphagia in esophageal cancer: a literature-based review.

Milind Javle, Sikander Ailawadhi, Gary Yang,

PubMed

2006

109

The CAR-HEMATOTOX score as a prognostic model of toxicity and response in patients receiving BCMA-directed CAR-T for relapsed/refractory multiple myeloma

Kai Rejeski, Doris K. Hansen, Radhika Bansal,

Journal of Hematology & Oncology

2023

95

Bendamustine and rituximab (BR) versus dexamethasone, rituximab, and cyclophosphamide (DRC) in patients with Waldenström macroglobulinemia

Jonas Paludo, Jithma P. Abeykoon, Amanda Shreders,

Annals of Hematology

2018

94

Page 1